Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

How would a Confidential Treatment Order request explain a silent period?

Here's the way that I have seen the CTO process work:
The company reaches an agreement of some kind with a second party. The terms of the agreement are such that the agreement requires an 8-K filing as a "Material Definitive Agreement." Some of the terms contain non-public information that could, in the judgment of the companies, cause competitive harm to the companies if they were to be revealed. Typically the companies would reach an agreement as to what should remain confidential.
The company files the 8-K including the agreement as an exhibit, redacting the information that it feels should remain non-public, while simultaneously filing a Confidential Treatment request with the SEC (see ***).
Some time later (possibly measurable in months depending on the complexity of the issues) the SEC, having reviewed the request, tells the company what they can and what they can't keep confidential in the form of a Confidential Treatment Order. The company then files an amended 8-K with the edited agreement, reflecting the authorized redactions, as an exhibit.


So if CTIX and "Pfiefer"....btw, is that Jules or Little Jackie?....had already reached an agreement but had yet to come to terms as to what should remain confidential, that might delay the filing of an 8-K.
Is that what you meant by "Leo asked for a CTO with a large pharmaceutical company (Pfiefer) and the SEC..."?

If Leo made a Confidential Treatment request we would have already seen the filing including a redacted agreement with Pfizer including a statement to that effect.

Please clear this up.



***
"Certain Confidential Information contained in this Exhibit was omitted by means of redacting a portion of the text and replacing it with an asterisk. This Exhibit has been filed separately with the Secretary of the Securities and Exchange Commission without the redaction pursuant to a Confidential Treatment Request under Rule 24b-2 of the Securities Exchange Act of 1934, as amended."